Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Anakinra by Swedish Orphan Biovitrum for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ): Likelihood of Approval
Anakinra is under clinical development by Swedish Orphan Biovitrum and currently in Phase III for Mucopolysaccharidosis III (MPS III) (Sanfilippo...
Anakinra by Swedish Orphan Biovitrum for Hospital Acquired Pneumonia (HAP): Likelihood of Approval
Anakinra is under clinical development by Swedish Orphan Biovitrum and currently in Phase II for Hospital Acquired Pneumonia (HAP). According...
Anakinra by Swedish Orphan Biovitrum for Community Acquired Pneumonia: Likelihood of Approval
Anakinra is under clinical development by Swedish Orphan Biovitrum and currently in Phase II for Community Acquired Pneumonia. According to...
Anakinra by Swedish Orphan Biovitrum for Cytokine Release Syndrome (Cytokine Storm): Likelihood of Approval
Anakinra is under clinical development by Swedish Orphan Biovitrum and currently in Phase II for Cytokine Release Syndrome (Cytokine Storm)....
Anakinra by Swedish Orphan Biovitrum for Intracerebral Hemorrhage: Likelihood of Approval
Anakinra is under clinical development by Swedish Orphan Biovitrum and currently in Phase II for Intracerebral Hemorrhage. According to GlobalData,...